北京绿竹生物技术股份有限公司（“绿竹生物-B”，02480）于2026年3月4日发布截至2026年2月28日的股份变动月报。公告显示，公司在报告期内未有新增股份发行及回购活动，股本结构保持稳定。
公司披露，截至2月底，已发行股份总数仍为202,449,032股，其中包括流通H股198,913,232股及库藏股3,535,800股。公司注册股本与上期一致，同为202,449,032股，每股面值人民币1元。报告期内未见购回与注销、也无任何新发行或认股权证、可换股票据及其他协议导致的股份变动。
公司表示，将继续遵守香港联合交易所有限公司《上市规则》及相关法律法规，并保证所有披露信息的真实性与准确性。公告由公司联席公司秘书刘斯宇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.